Oct2, BCL6, IRF8, OCAB and PU.1 in the Assessment of Prognosis in Diffuse Large B cell Lymphoma Patients

@article{Ea2016Oct2BI,
  title={Oct2, BCL6, IRF8, OCAB and PU.1 in the Assessment of Prognosis in Diffuse Large B cell Lymphoma Patients},
  author={Rojas-Bilbao Ea and M. E. Knott and Balashova Ed and M. Zerga and M. N{\'u}{\~n}ez and L. Puricelli and S. Ranuncolo},
  journal={Journal of Molecular Biomarkers \& Diagnosis},
  year={2016},
  volume={7},
  pages={1-9}
}
Background: Diffuse Large B-Cell Lymphoma (DLBCL) is the most common type of Non-Hodgkin Lymphoma in adults. This germinal center derived B cell lymphoma is a heterogeneous disease with a highly variable clinical course, currently treated with immune-chemotherapy. The International Prognosis Index (IPI) remains the main prognosis indicator. This highlights the absence of biomarkers suitable to provide molecular biology information to more accurately establish prognosis and predict treatment… Expand
1 Citations

References

SHOWING 1-10 OF 62 REFERENCES
LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab.
  • Y. Natkunam, P. Farinha, +17 authors I. Lossos
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2008
SnapShot: diffuse large B cell lymphoma.
A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy
Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.
  • K. Fu, D. Weisenburger, +10 authors J. Vose
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2008
Expression and prognostic significance of Oct2 and Bob1 in multiple myeloma: implications for targeted therapeutics
The genetic basis of diffuse large B-cell lymphoma
...
1
2
3
4
5
...